# ZELAPAR

NDC: 0187-0453
Generic name: SELEGILINE HYDROCHLORIDE
Labeler / Manufacturer: Bausch Health US, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20060614

FDA application: NDA021479

## Active ingredients

- SELEGILINE HYDROCHLORIDE: 1.25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0187-0453"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0187-0453
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=380d7717-2a79-42f3-a712-efe5e7696ba0